Financials
- Market Capitalization 40.56 M
- Employee 12
- Founded 2001
- CEO Joel Latham
- Website www.incannex.com.au
- Headquarter Delaware, United States
- FIGI BBG01J0814Y2
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.16
Relación precio/flujo de caja
86.42
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4281 | INCR Intercure Ltd. - ordinary shares | 0.98 USD | +3.16% | +1.03% | +8.89% | -36.77% | 53.59 M USD | ||
| 4353 | SCYX SCYNEXIS, Inc. - Common Stock | 4.62 USD | +3.13% | +1.32% | +8.71% | +470.37% | 45.88 M USD | ||
| 4453 | ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 0.74 USD | +4.23% | +5.71% | -1.33% | -69.67% | 35.07 M USD | ||
| 4550 | CPHI China Pharma Holdings, Inc. Common Stock | 0.60 USD | 0.00% | -4.76% | -24.05% | -9.24% | 24.31 M USD |